HeyJaredLaura Howes
- Indexed articles, last 90 days
- 1
- Latest publication
- Jul 16, 2026
- Outlet visibility, for Chemical & Engineering News
- Top 500K sites
- Earliest in this view
- Jul 16, 2026
Latest articles
FDA approves first oral PCSK9 inhibitor for managing cholesterol (opens the original)
Read excerpt
FDA approves first oral PCSK9 inhibitor for managing cholesterol Merck & Co.'s macrocyclic peptide enlicitide to be marketed as Lipfendra The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. The US Food and Drug Administration has approved Merck & Co.’s cyclic peptide enlicitide decanoate for the reduction of low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia. The drug, whi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Chemical & Engineering News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.